(Q63319645)

English

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

JAKARTA2 (English)

0 references

title

A Phase II, Multicenter, Open Label, Single Arm Study of SAR302503 in Subjects Previously Treated With Ruxolitinib and With a Current Diagnosis of Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis (English)

0 references

medical condition

chronic idiopathic myelofibrosis

0 references

0 references

0 references

0 references